Pharma company Moderna and Pfizer, which is engaged in the manufacture of Corona vaccine, have now reached the final stage of testing. Pharmaceutical companies have started two trials in two groups of 30–30 thousand people. Only on the basis of this test, companies can get all the necessary permission, after which they will be able to use it on common people, and can market it. Pharmaceutical companies are trying to launch this vaccine by the end of this year.

These two tests being conducted on 2 different groups are part of the decisive test of the vaccine. The US government is helping to develop this vaccine. The government wants that there is no unnecessary delay in the tests and that the epidemic can be brought under control by developing the vaccine on time. According to the pharmaceutical companies, new technology is being used in testing to replace the already prevalent methods in the manufacture of vaccines so that time can be saved and the vaccine can be introduced in the market soon. Moderna has received $ 100 million from the US government to develop the vaccine. At the same time, on the condition of the vaccine working, the US government has tied up with Pfizer to make the vaccine available to 50 million American citizens, which will cost around $ 200 million.

Currently, 150 candidates are working to produce vaccines worldwide, of which more than 20 have already started testing their vaccine on humans. Considering the progress in the manufacture of vaccine regarding the corona epidemic, the stock markets have also seen positive effects. Moderna’s stock rose 9 percent in the US market. Pfizer’s stock rose 1.6 percent. BioNTech, a subsidiary of Pfizer, which develops the vaccine, has gained 4.2 per cent in stock.